Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Digital Pathology Market, by Product
1.4.2 North America Digital Pathology Market, by End Use
1.4.3 North America Digital Pathology Market, by Application
1.4.4 North America Digital Pathology Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2021, Feb) Leading Players
Chapter 4. North America Digital Pathology Market by Product
4.1 North America Device Market by Country
4.2 North America Software Market by Country
4.3 North America Storage System Market by Country
Chapter 5. North America Digital Pathology Market by End-use
5.1 North America Hospitals Market by Country
5.2 North America Diagnostic Labs Market by Country
5.3 North America Biotech & pharma companies Market by Country
5.4 North America Academic & research institutes Market by Country
Chapter 6. North America Digital Pathology Market by Application
6.1 North America Drug Discovery & Development Market by Country
6.2 North America Disease Diagnosis Market by Country
6.3 North America Academic research Market by Country
Chapter 7. North America Digital Pathology Market by Country
7.1 US Digital Pathology Market
7.1.1 US Digital Pathology Market by Product
7.1.2 US Digital Pathology Market by End-use
7.1.3 US Digital Pathology Market by Application
7.2 Canada Digital Pathology Market
7.2.1 Canada Digital Pathology Market by Product
7.2.2 Canada Digital Pathology Market by End-use
7.2.3 Canada Digital Pathology Market by Application
7.3 Mexico Digital Pathology Market
7.3.1 Mexico Digital Pathology Market by Product
7.3.2 Mexico Digital Pathology Market by End-use
7.3.3 Mexico Digital Pathology Market by Application
7.4 Rest of North America Digital Pathology Market
7.4.1 Rest of North America Digital Pathology Market by Product
7.4.2 Rest of North America Digital Pathology Market by End-use
7.4.3 Rest of North America Digital Pathology Market by Application
Chapter 8. Company Profiles
8.1 Danaher Corporation (Leica Biosystems)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental &Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Koninklijke Philips N.V.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Olympus Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 ContextVision AB
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Approvals:
8.6 Hamamatsu Photonics K.K.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.7 Mikroscan Technologies, Inc.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Inspirata, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Acquisition and Mergers:
8.9 Visiopharm A/S
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Product Launches and Product Expansions:
8.9.2.3 Acquisition and Mergers:
8.10. 3DHISTECH Ltd.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
Unique Offerings 